Database updated: 27 October 2026
Safety Information
Medsafe Online Recall Database
Detail of Recall
| Type of Product: | Medicine |
| Medsafe Reference: | 27999 |
| Brand Name: | Nucala |
| Dose Form/Strength: | Solution for injection 100 mg/mL Pre-filled Pen |
| Affected: | 3U3J and A72Y |
| Recalling Organisation: | GlaxoSmithKline NZ Limited Aon Centre Level 12/29 Customs Street West Auckland CBD Auckland 1010 |
| Contact Information: | (09) 367 2914 |
| Manufacturer: | Glaxo Operations UK Limited t/a Glaxo Wellcome Operations |
| Issue: | GlaxoSmithKline (GSK) NZ Limited is recalling two batches (3U3J and A72Y) of NUCALA solution for injection (mepolizumab 100 mg/mL) pre-filled pen (Autoinjector) to pharmacy level as they have identified one case where a fibre is trapped by the stopper against the wall of the syringe and is both in the liquid and above the stopper, compromising the integrity of the affected syringe. As a precautionary measure, a decision has been made that all finished product batches packed using the impacted bulk product batch will be recalled from pharmacies, wholesalers and external warehouses and distributers. |
| Recall action type: | Recall |
| Recall action: | Recall |
| Level of recall: | Hospital/Pharmacy/Laboratory |
| Date Commenced: | 13/7/2021 |
